Extended Data Fig. 10: Single therapeutic treatment with combinational colon-specific immune niches effectively ameliorates colitis symptoms in a chronic dextran sodium sulfate-induced colitis model.
From: An injectable subcutaneous colon-specific immune niche for the treatment of ulcerative colitis
a, b, Disease activity index score (a) and bodyweight (b) change after treatment(s) with combinational colon-specific immune niche. c, Digital photographs and length of colons preserved at the study endpoint (48 days after the initial colitis induction) after one or three therapeutic treatments with the combo immune niche. d, Representative H&E-stained images, colon epithelial damage score, inflammatory cell infiltration score, and colonic damage score of colons preserved at the study endpoint (48 days after the first induction of colitis) after one or three therapeutic treatments with combinational colon-specific immune niche.
